Monday, March 19, 2007

Nanomedicine at Johns Hopkins

As anyone who has been reading nanotech news for any part of the past few years knows, the impact that nanotechnologies will play on medicine is potentially enormous. Nanotechnologies will play a role in the screening, diagnosis, monitoring and treatment of disease, and will likely be a major contributor to the continued lengthening of the human lifespan as well as the greater enjoyment of those years.

The following is just one of many interviews I did as Editor of Nanotechnology Now on nanomedicine.

Here is an excerpt of my interview with Dr. Peter Searson, director for the Johns Hopkins Institute for NanoBioTechnology. He is also a professor in Materials Science and Engineering in the Whiting School of Engineering and is Associate Director of the Materials Research Science and Engineering Center.

RR: Looking out ten years, what are your hopes regarding medical diagnostics and treatments stemming from our understanding of the nanoscale?

Very simply, we will develop new scientific tools and create new technologies for the diagnosis and treatment of diseases and medical conditions. We will develop new tools will allow us to develop a better understanding of how cells function, and misfunction, at the molecular level. Research will also focus on the development of new diagnostic and therapeutic strategies, for example, for the early detection and treatment of cancer.

Read the entire interview here:

No comments: